The companies announced the data as an industry conference in Las Vegas.
Medtronic and Boston Scientific announced study results Friday that they said reflected positively on devices they are selling in the fast-growing field of neuromodulation.
Boston Scientific Corp. presented new clinical trial findings Friday for patients using two different modes in a spinal cord stimulation system, while Medtronic announced the results of a long-running trial of its implantable drug pump for patients with muscle spasticity following a stroke. The companies announced the data as an industry conference gathered this week in Las Vegas.
